Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody

Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee and June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;
Kyung Oh Jung
2Biomedical Sciences, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
5Cancer Imaging Center, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mi Jeong Kim
1Department of Nuclear Medicine, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Soo Lee
6Molecular Medicine and Biopharmaceutical Sciences, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
4Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 276

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Kyung Oh Jung2,
  2. Hyewon Youn5,
  3. Mi Jeong Kim1,
  4. Keon Wook Kang3,
  5. Dong Soo Lee6 and
  6. June-Key Chung4
  1. 1Department of Nuclear Medicine, Seoul National University, Seoul, Republic of Korea
  2. 2Biomedical Sciences, Seoul National University, Seoul, Republic of Korea
  3. 3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea
  4. 4Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, Republic of Korea
  5. 5Cancer Imaging Center, Seoul National University, Seoul, Republic of Korea
  6. 6Molecular Medicine and Biopharmaceutical Sciences, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014300
Dec 2014300
Jan 2015200
Feb 2015100
Apr 2015700
May 2015300
Jun 2015100
Jul 20151200
Aug 2015500
Sep 20151000
Oct 2015400
Nov 2015200
Dec 2015300
Jan 2016600
Mar 2016200
Apr 2016300
May 2016300
Jun 2016500
Jul 2016300
Aug 2016500
Sep 2016800
Oct 2016400
Nov 2016200
Dec 2016100
Jan 2017200
Feb 2017300
Mar 2017500
May 20171400
Jul 2017300
Aug 2017600
Sep 2017400
Dec 2017100
Feb 2018100
Mar 2018500
Apr 2018700
May 2018800
Jun 2018900
Jul 2018600
Aug 2018300
Sep 2018900
Oct 20181300
Nov 20181500
Dec 2018800
Mar 2019200
Apr 20191200
May 2019100
Jun 2019500
Jul 2019300
Aug 2019300
Sep 2019100
Oct 2019100
Nov 2019100
Dec 2019100
Jan 2020400
Feb 2020700
Mar 20201400
Apr 2020800
May 2020400
Jun 2020100
Jul 2020800
Aug 20201700
Sep 20202900
Oct 20201700
Nov 20201500
Dec 20201200
Jan 2021600
Feb 20211200
Mar 2021800
Apr 2021800
May 2021800
Jun 2021400
Jul 20211300
Aug 20213200
Sep 20211500
Oct 20213000
Nov 20216900
Dec 20214500
Jan 20226700
Feb 20222100
Mar 20221400
Apr 20221200
May 20222300
Jun 2022100
Jul 2022800
Aug 2022200
Sep 2022300
Oct 2022500
Nov 2022100
Dec 2022100
Jan 2023600
Feb 2023100
Mar 2023200
Apr 2023100
May 2023300
Jun 2023300
Jul 2023200
Aug 2023400
Sep 2023500
Oct 2023400
Nov 2023800
Dec 2023600
Jan 2024400
Feb 2024400
Mar 2024400
Apr 2024600
May 20241200
Jun 2024200
Aug 20241100
Sep 2024400
Oct 2024300
Nov 20242400
Dec 2024400
Jan 2025300
Feb 2025400
Mar 2025300
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee, June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee, June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Antibody, Nanoparticle and Cell-Based Oncology Probes

  • Preclinical evaluation of anti-αvβ6 diabodies and anti-αvβ6 cys-diabodies for imaging αvβ6-positive tumors with positron emission tomography
  • PET of follicle-stimulating hormone receptor: Broadly applicable for imaging of cancer
  • 111In-anti-F4/80 for in vivo tracking of tumor associated macrophages
Show more Antibody, Nanoparticle and Cell-Based Oncology Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire